Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

January, 2013 - December, 2015

Data type

Scientific literature

Keywords

Antiretroviral therapy, HIV and AIDS, Health care costs, Health care economics, Health care expenditures

Citation

Authors

Peng S, Tafazzoli A, Dorman E, Rosenblatt L, Villasis-Keever A, Sorensen S

Journal

J Med Econ

Pages

763-76

Publication year

2015

Suggested citation

Peng S, Tafazzoli A, Dorman E, Rosenblatt L, Villasis-Keever A, Sorensen S. Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States. J Med Econ. 2015; 18(10): 763-76.